Tylenol tied to blood cancer

Chronic users of acetaminophen (Tylenol) have a higher risk of developing blood cancer, according to a study published this week in the Journal of Clinical Oncology.

Jef Akst
Jef Akst

Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf...

View full profile.


Learn about our editorial policies.

May 14, 2011

IMAGE: WIKIMEDIA COMMONS, KATY WARNERChronic users of acetaminophen (Tylenol) have a higher risk of developing blood cancer, according to a study published this week in the Journal of Clinical Oncology. The increased risk is small, but the finding adds to a growing body of literature that links cancer and painkillers (see last month's feature on the topic for more information). Previous work, for example, suggested that aspirin increases the chances of colon cancer survival, while also increasing the risk of bleeding ulcers, according to Reuters. It's still unclear, however, whether acetaminophen causes cancer, said study coauthor Emily White of the Fred Hutchinson Cancer Research Center in Seattle.

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?